In a filing, AEON Biopharma Inc revealed its Director FISCHER JOST acquired Company’s shares for reported $29250.0 on May 21 ’25. In the deal valued at $0.49 per share,60,000 shares were bought. As a result of this transaction, FISCHER JOST now holds 266,785 shares worth roughly $0.21 million.
Then, FISCHER JOST bought 60,000 shares, generating $30,360 in total proceeds. Upon buying the shares at $0.51, the Director now owns 206,785 shares.
Before that, FISCHER JOST bought 50,000 shares. AEON Biopharma Inc shares valued at $24,940 were divested by the Director at a price of $0.50 per share. As a result of the transaction, FISCHER JOST now holds 146,785 shares, worth roughly $0.12 million.
H.C. Wainwright initiated its AEON Biopharma Inc [AEON] rating to a Buy in a research note published on August 18, 2023; the price target was $18.
Price Performance Review of AEON
On Tuesday, AEON Biopharma Inc [AMEX:AEON] saw its stock jump 4.89% to $0.8. Over the last five days, the stock has gained 12.60%. AEON Biopharma Inc shares have fallen nearly -98.97% since the year began. Nevertheless, the stocks have fallen -97.95% over the past one year. While a 52-week high of $269.28 was reached on 01/03/25, a 52-week low of $0.38 was recorded on 04/11/25.
Levels Of Support And Resistance For AEON Stock
The 24-hour chart illustrates a support level at 0.7481, which if violated will result in even more drops to 0.6991. On the upside, there is a resistance level at 0.8281. A further resistance level may holdings at 0.8591.
How much short interest is there in AEON Biopharma Inc?
A steep rise in short interest was recorded in AEON Biopharma Inc stocks on 2025-06-13, growing by 0.26 million shares to a total of 0.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.18 million shares. There was a rise of 59.24%, which implies that there is a positive sentiment for the stock.
